- Home
- MDAI vs DARE Comparison
MDAI vs DARE Comparison
Compare MDAI & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- DARE
- Stock Information
- Founded
- MDAI 2013
- DARE 2015
- Country
- MDAI United States
- DARE United States
- Employees
- MDAI N/A
- DARE N/A
- Industry
- MDAI Medical/Dental Instruments
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- MDAI Health Care
- DARE Health Care
- Exchange
- MDAI Nasdaq
- DARE Nasdaq
- Market Cap
- MDAI 51.5M
- DARE 26.3M
- IPO Year
- MDAI N/A
- DARE N/A
- Fundamental
- Price
- MDAI $2.85
- DARE $2.46
- Analyst Decision
- MDAI Strong Buy
- DARE Strong Buy
- Analyst Count
- MDAI 2
- DARE 3
- Target Price
- MDAI $4.75
- DARE $12.50
- AVG Volume (30 Days)
- MDAI 633.9K
- DARE 39.6K
- Earning Date
- MDAI 08-11-2025
- DARE 08-11-2025
- Dividend Yield
- MDAI N/A
- DARE N/A
- EPS Growth
- MDAI N/A
- DARE N/A
- EPS
- MDAI N/A
- DARE N/A
- Revenue
- MDAI $29,962,000.00
- DARE $25,909.00
- Revenue This Year
- MDAI N/A
- DARE $99,756.91
- Revenue Next Year
- MDAI $15.14
- DARE $119.77
- P/E Ratio
- MDAI N/A
- DARE N/A
- Revenue Growth
- MDAI 55.21
- DARE N/A
- 52 Week Low
- MDAI $0.82
- DARE $2.35
- 52 Week High
- MDAI $3.25
- DARE $4.60
- Technical
- Relative Strength Index (RSI)
- MDAI 73.60
- DARE 35.15
- Support Level
- MDAI $2.56
- DARE $2.37
- Resistance Level
- MDAI $2.75
- DARE $2.54
- Average True Range (ATR)
- MDAI 0.17
- DARE 0.11
- MACD
- MDAI 0.05
- DARE -0.02
- Stochastic Oscillator
- MDAI 94.62
- DARE 17.50
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.